Raymond James Financial Services Advisors’s Profound Medical PROF Stock Holding History
Bought
Maintained
Sold
Other funds holding PROF
GS
LBA
TIM
GA
RA
RA
AAP
Raymond James Financial Services Advisors's PROF Position: Q3 2024 in Review
Raymond James Financial Services Advisors increased its Profound Medical (PROF) stake by 12% in Q3 2024, buying an estimated $713K and bringing the position to 760,457 shares worth $6.05M. The position accounts for 0.01% of the portfolio, ranked #1126.
Raymond James Financial Services Advisors first reported a position in PROF in Q1 2020 and has held it in 19 quarters since. The position peaked at $7.56M in Q2 2023. 44 funds tracked by Wall St. Rank hold PROF as of Q3 2024.
- Raymond James Financial Services Advisors held 760,457 shares of Profound Medical worth $6.05M as of Q3 2024.
- Raymond James Financial Services Advisors bought 78,895 Profound Medical shares in Q3 2024, an estimated $713K.
- Profound Medical made up 0.01% of Raymond James Financial Services Advisors's portfolio in Q3 2024, its #1126 holding.
- Raymond James Financial Services Advisors first reported a position in Profound Medical in Q1 2020 and has held it in 19 quarters since.
- Raymond James Financial Services Advisors's Profound Medical position peaked at $7.56M in Q2 2023.
- 44 funds tracked by Wall St. Rank held Profound Medical as of Q3 2024.
Based on Raymond James Financial Services Advisors's 13F filing for Q3 2024, filed 18 Oct 2024.